Posted on Facebook a half hour ago.
Dear John,
I write
Posted on Facebook a half hour ago.
Dear John,
I write to you again as the voice of reason in the hope you can answer some very basic questions for me regarding our investment in FITX. To say we're confused & concerned at he most recent turn of events & the PR last week that announced the potential spin off of Cen Bio & the immediate resignation of the board & directors of Creative Edge Nutrition is a vast understatement.
1) Have you all resigned already?
2) What happens to the MJ side if there is no spin off?
3) Who is the man that has taken over of CEO of Creative Edge Nutrition?
4) What will the share distribution be of the spin off, e.g. If we have 2mm shares of FITX how many will we get of the spin off company?
The reason I ask these most basic questions is because the PR was very poorly worded & left far more questions than answers. I'm confused as to why there was no link to James Robinson's name where one could read his bio or learn who he is. What happens to Cen Bio & the MJ plans if the spin off doesn't happen? My biggest question is this: As of today do we own 2mm shares of a nutrition & supplement company or is everything status quo until the spin off occurs?
Where is Mr. Chabaan? Is he still traveling overseas or is he in the USA trying to resolve the issues with zoning in Lakeshore? We are begging you to respond as quickly as you have in the past & be as candid as you can. We are not alone in our concerns, there are MANY hundreds of hard working people that have invested life savings into FITX that are looking for answers to these questions. Maybe it's time for a PR with substance & clarity.
I thank you in advance.
RESPONSE
Ms. Xxxxxxxxc
Thank you for taking the time to contact John and the company. I can assure you our corporate vision remains the same. All of our actions are taken in the best interest of the shareholders... All shareholders. In the near future, we will answer most if not all of your questions.
The Current board remains intact until our legal formalities are followed. Our press release was reviewed by 4 sec attorneys. We ensure we follow the letter of the law. It was not intentionally vague; that was the product of the multiple reviews by our legal counsel.
Regarding my travel schedule and the operation of the business ... It is also absolutely necessary. I can assure you I am not on vacation. My attendance is not required at all meetings, including Lakeshore council meetings. I have a very capable staff who have clear instructions and access to me 24/7 - 365 regardless where I am in the world. My job is to continue to move this company forward through our multiple projects... Not just one.
I thank you for being a shareholder. Unfortunately we cannot counsel you on keeping or selling your shares.
Yours very truly
Bill CHAABAN
president & CEO
Creative Edge Nutrition
CEN Biotech Inc
Creative Edge Nutrition Inc. (FITX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
STING Agonists: The Next Frontier in Glioblastoma Treatment? Out there in the weeds of immunotherapy, ImmunoGenesis is gearing up for its moment at the SITC 2026 Annual Meeting with its STING agonist, IMGS-203. The stakes are skyscraper-high as this novel treatment makes a play against recurrent glioblastoma (GBM)—one tough cookie in the realm of brain cancers....
Continue Reading
The Rise of Peptide Education Imagine you're wading through a bog of health trends. That's how it feels trying to get a grip on peptide therapies these days, right? Luckily, PeptideWorld, powered by e?vita Health, is here to toss you a lifeline. They're transforming the landscape with a mission to ditch the marketing mumbo-jumbo for hard science. Their pitch?...
Continue Reading
Rough Waves for FIS Shareholders If there’s one thing I've learned chewing on greasy bacon over the years, it's that nothing rattles a stock like sketchy numbers and shattered investor confidence. Fidelity National Information Services, or FIS, has just yanked the rug out from its own 2026 forecast, cutting adjusted earnings per share (EPS) to a range of $5.82 to $5.89....
Continue Reading
Basildon's New Housing Beacon Nears Completion No two construction milestones are the same, and Starlight Investments sure knows how to make theirs count. Reaching the skies with their project 'The Mercantile' in Basildon, the company has announced topping out—a significant phase in their build-to-rent development saga. With the structural peak reached, we're talking...
Continue Reading
Bluevua Sweeps the 2026 BASA Awards Stacking accolades like old trading wins, Bluevua just clinched not one, not two, but three 2026 Best of America Small Business Awards (BASA Awards®). If that's not a feather in their cap, I don't know what is. For the uninitiated, these BASA nods are no small potatoes—they're like the Oscars for small businesses. Bluevua, known for...
Continue Reading
Paving the Future with Patents Ah, patents. Like stock dividends for the tech world—they don’t change everything outright but can signal some mighty good things ahead. This time around, it’s Satisfi Labs who are in the spotlight. They’ve bagged not one, but two shiny U.S. patents to bolster what they’re calling Satisfi Forward. Honestly, it sounds like a...
Continue Reading
Omnicom Media's Latest Triumph Omnicom Media (NYSE: OMC) just snagged the 'Leader' badge in the ruthless world of media management services, according to Forrester's new report. Picture a chess game where every move counts—Omnicom's been playing for years, and they're a grandmaster at this point. This isn't some pat on the back; it's recognition of a powerhouse...
Continue Reading
Leaders of Tomorrow: Campus News Awards 2026 It's no small feat to look at a room full of young journalists and see the future of how stories will be told. But that's exactly what happened at the Campus News Awards 2026 in Shenzhen. Here, kids from Hong Kong, Macao, Taiwan, and Southeast Asia stood proudly with their certificates, ready to tackle the changing landscape of...
Continue Reading
A Dual Milestone: Leadership and Recognition In an industry chock-full of buzzwords, New Story’s latest moves cut through the noise. They've just announced Adam Drudge as their new Chief People Officer, and wouldn't you know it, they've snagged their third straight Most Loved Workplace® recognition for 2026. When a special ed company starts making waves like this,...
Continue Reading
Turning Plastic into Gold Well, folks, Crocs isn't just about comfort anymore. They're wrapping their iconic Classic Clog in a shiny new accolade: Cradle to Cradle Certified® Circularity Gold Version 5.0. Imagine that—an award for making something meant to last, designed to be repurposed. They're not just slapping new paint on the same old clogs either. This...
Continue Reading
Top 5 Most Recently Viewed Articles
Introducing the Arlo Wired Floodlight Camera Arlo Technologies, Inc. (NYSE: ARLO), known for its leading smart home security solutions, has introduced an enhanced Wired Floodlight Camera. This innovative all-in-one DIY security solution builds on the company's successful line of wire-free floodlights, leveraging advanced technology to ensure that your outdoor spaces are...
Continue Reading
Bruce Berkowitz's Significant Sell-Off of St. Joe Shares Recently, it was reported that BRUCE BERKOWITZ, a notable stakeholder of St. Joe (NYSE: JOE), executed a significant sell-off of his shares. According to a filing with the SEC, Berkowitz sold 71,900 shares at a total value of approximately $4.48 million. Such actions from insiders often draw the attention of...
Continue Reading
Yaamava' Resort & Casino Continues to Impress Critics and Guests Year after year, Yaamava' Resort & Casino at San Manuel has made a remarkable mark in the gaming industry, consistently rising to the top of prestigious rankings. Most recently, the resort secured its status once again by being voted the Best Overall Casino Outside of Las Vegas and Best Native American...
Continue Reading
Maro Secures Significant Seed Funding to Combat Cybersecurity Risks Maro, an innovative player in cognitive security, has successfully raised $4.3 million from Downing Capital Group. This funding is set to empower companies to better manage human risks associated with cybersecurity, transforming the way organizations deal with elements such as social engineering, insider...
Continue Reading
Understanding B7-H3 Inhibitors and Their Impact on Cancer Treatment The B7-H3 inhibitors market is rapidly emerging as a transformative force in oncology. The significant increase in investment from pharmaceutical giants alongside a rising number of cancer diagnoses has heightened interest and research in this area. This class of inhibitors aims to target the B7-H3...
Continue Reading